URM and Student with Disabilities
Percentage of number of URM and student with disabilities in the program and graduated: 18% (7 out 40), 100% graduated
Career placement of those students:
- Biotech – 29% - Gatan, Parkinson’s Association
- Government Science – 29% - CDC, CIA
- Pharma – 14% - Capricor
- Regulatory Science -14% - FDA
- Scientific Writing – 14% - Project Lead the Way
CTEng Alumni Profiles
Andres Bratt-Leal, Ph.D.
Ivana Parker, Ph.D.
Ivana worked to investigate the role of cathepsins, potent elastases and collagenases, in the progression of HIV - related cardiovascular disease with Dr. Manu Platt. Her research investigated the effects of hemodynamic environment and HIV-proteins or antiretroviral regiment on cathepsin activity in arterial cells. This work was performed using an HIV-tg mouse model, and verified using human endothelial cells systems and a shear stress bioreactor. Her work demonstrated that the upregulation of cathepsins in vivo and in vitro is caused by a synergism between pro-atherogenic shear stress and HIV-1 proteins and elucidated pathways that are activated by HIV-1 Tat and pro-atherogenic shear stress - leading to cathepsin-mediated ECM degradation.
She recently received the ASM/CDC Program in Infection Disease and Public Health Microbiology Postdoctoral Research Fellowship where she will be working at the National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID). Her work there will aim to improve the monitoring of HIV incidence, the number of new infections, by developing bioplex assays, and identifying biomarkers for accurate recent infection detection.